Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways.
Oliver S EngAndrew M BlakelyKelly J LafaroKeith F FournierNadege T FackcheFabian M JohnstonSean DineenBenjamin D PowersRyan HendrixLaura A LambertSean Ronnekleiv-KellyKara Vande WalleTravis E GrotzJennifer L LeitingSameer H PatelVikrom K DharJoel M BaumgartnerAndrew M LowyCallisia N ClarkeHarveshp MogalMohammad Y ZaidiCharles A StaleyCharles KimbroughJordan M CloydByrne LeeMustafa RaoofPublished in: Journal of surgical oncology (2020)
Significant variation exists in the perioperative care of patients undergoing CRS/HIPEC at major US academic institutions. These findings provide a strong rationale for the investigation of best practices in CRS/HIPEC patients.
Keyphrases
- patients undergoing
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- minimally invasive
- chronic kidney disease
- clinical trial
- prognostic factors
- squamous cell carcinoma
- coronary artery bypass
- quality improvement
- locally advanced
- acute coronary syndrome
- atrial fibrillation
- pain management
- surgical site infection
- patient reported outcomes